Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Whats Inside
GLP-1 receptor agonists may offer a new approach that can complement existing topical, systemic and biologic treatment options. Across the trials, clinicians treated participants with one of three GLP-1s 81.5% received semaglutide (Wegovy, Novo Nordisk), 17.4% received liraglutide and 1% received tirzepatide (Zepbound, Eli Lilly) at varying dosages and treatment durations
Tirzepatide is a dual GLP-1 and GIP receptor agonist, activating both pathways simultaneously
Practical Tip: Prioritize protein at every eating occasion
US$ 28.61
US$ 27.91
US$ 25.35
US$ 28.83
US$ 20.92
US$ 24.91
US$ 23.08
US$ 28.50
